Advertisement
Bio-Techne, Akoya To End Co-development Of RNAscope For Use With PhenoCycler-Fusion System
(RTTNews) - Life sciences company Bio-Techne Corp. (TECH) announced Monday that the company will end their collaboration with Akoya Biosciences to co-develop an automated RNAscope workflow for use with the PhenoCycler-Fusion System. The decision was made following best efforts to achieve the intended program goals.
Bio-Techne said it plans to accelerate the development and commercialization of the first fully automated and scalable spatial multiomics workflow on the Lunaphore COMET system.
Bio-Techne will continue to support its customers utilizing RNAscope assays in conjunction with Opal reagents and PhenoImager HT systems purchased from Akoya.
read more
Bio-Techne Q2 Results Miss Estimates; Declares Dividend
Life sciences company Bio-Techne Corp. (TECH) reported Thursday that second-quarter net earnings attributable to the company almost halved to $27.47 million or $0.17 per share from $50.01 million or $0.31 per share in the prior-year quarter.
RTTNews
|
446 дней спустя
Bio-Techne Files Drug Master File With FDA For ExCellerate GMP IPSC Expansion Medium
Bio-Techne Corp. (TECH) announced Wednesday that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ExCellerate GMP iPSC Expansion Medium, Animal Free (CCM0036-GMP), supporting the development and manufacture of regenerative medicine and stem cell therapies.
RTTNews
|
489 дней спустя
Bio-Techne Promotes Kim Kelderman To Succeed Chuck Kummeth As President And CEO
Bio-Techne Corp. (TECH) announced Thursday that its Board of Directors appointed Kim Kelderman as President and Chief Executive Officer, effective February 1, 2024. Kelderman will also become a member of the Board of Directors on the same day.
RTTNews
|
551 дней спустя
Bio-Techne To Acquire Namocell For Undisclosed Terms
Life sciences company Bio-Techne Corp. (TECH) announced Wednesday it has reached an agreement to acquire Namocell, Inc., a provider of fast and easy to use single cell sorting and dispensing platforms that are gentle to cells, and preserve cell viability and integrity.
RTTNews
|
1035 дней спустя
Roche To Invest $50 Bln In U.S; To Create 12,000 Jobs
Amid the ongoing tariff issues, Swiss drug major Roche Holding AG announced its plan to invest $50 billion in the United States in the next five years, aiming to expand its Pharmaceutical and Diagnostics Divisions. With all new and expanded manufacturing capacity, Roche aims to export more medicines from the US than it imports.
RTTNews
|
3ч 20мин назад
Bay Street Likely To Open On Cautious Note
The Canadian market is likely to open on a cautious note Tuesday morning, but some buying is likely in energy and materials sectors thanks to firm commodity prices.
Worries about trade tensions and the stand-off between U.S. President and the Fed Chair might hurt sentiment and limit market's upside.
RTTNews
|
3ч 22мин назад
FTSE 100 Up Marginally; Sainsbury Rises After Announcing Buyback Program
U.K. stocks are modestly higher on Tuesday, led by gains in retailers and consumer staples stocks, even as the mood remains cautious amid lingering concerns about global economic growth due to trade tensions following the U.S. government's highly protectionist trade policy.
RTTNews
|
5ч 7мин назад
Sensex, Nifty End Higher Despite Weak Global Cues
Indian shares ended slightly higher on Tuesday despite weak cues from global markets.
RTTNews
|
5ч 29мин назад
